ArticleTransplantation and cellular therapy2022

Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation.

Eleni Karantoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.